Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Versor Investments LP

Versor Investments LP lessened its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 39.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,557 shares of the company’s stock after selling 14,543 shares during the quarter. Versor Investments LP’s holdings in Oscar Health were worth $303,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of OSCR. State Street Corp grew its stake in Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after buying an additional 291,335 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after acquiring an additional 455,205 shares in the last quarter. Hennessy Advisors Inc. boosted its position in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after purchasing an additional 3,544,300 shares during the period. JPMorgan Chase & Co. boosted its position in Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after purchasing an additional 938,742 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Oscar Health by 20.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock valued at $33,940,000 after purchasing an additional 270,223 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on OSCR shares. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Oscar Health currently has a consensus rating of “Hold” and a consensus target price of $21.56.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $15.07 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a fifty-two week low of $12.43 and a fifty-two week high of $23.79. The business has a 50 day moving average price of $15.00 and a two-hundred day moving average price of $16.55. The firm has a market cap of $3.78 billion, a PE ratio of -753.12 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Sell-side analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.